To ensure our target genes were successfully cloned into the pSB1C3 backbone, we ran the electrophoresis of Taq PCR products to check the sizes of the insert genes.
(Created page with "{{NCTU_Formosa/test}} <html> <head> <meta charset="UTF-8"> <title>Protein Expression</title> <script src="https://ajax.googleapis.com/ajax/libs/jquery/3.2.1/jquery.min....") |
|||
(141 intermediate revisions by 9 users not shown) | |||
Line 23: | Line 23: | ||
padding: 0 !important; | padding: 0 !important; | ||
width: 100%; | width: 100%; | ||
+ | overflow: auto; | ||
} | } | ||
.wrapper{ | .wrapper{ | ||
width: 100%; | width: 100%; | ||
− | overflow: | + | overflow: hidden; |
+ | padding-bottom: 150px; | ||
} | } | ||
.cover{ | .cover{ | ||
width: 100%; | width: 100%; | ||
+ | position: relative; | ||
} | } | ||
+ | .title_title{ | ||
+ | width: 50%; | ||
+ | margin-left: 25%; | ||
+ | padding-top: 100px; | ||
+ | } | ||
.title{ | .title{ | ||
font-size: 7vmin; | font-size: 7vmin; | ||
− | + | padding-top: 40px; | |
− | + | ||
text-align: center; | text-align: center; | ||
} | } | ||
.title_1{ | .title_1{ | ||
− | font-size: | + | font-size: 7vmin; |
width: 75%; | width: 75%; | ||
margin: 50px; | margin: 50px; | ||
− | |||
margin-left: 12.5%; | margin-left: 12.5%; | ||
+ | margin-bottom: 20px; | ||
} | } | ||
Line 65: | Line 72: | ||
.text{ | .text{ | ||
− | font-size: | + | font-size: 3vmin; |
width: 75%; | width: 75%; | ||
position: relative; | position: relative; | ||
Line 87: | Line 94: | ||
table{ | table{ | ||
− | width: | + | width: 45%; |
border: solid 2px #e7eceb; | border: solid 2px #e7eceb; | ||
text-align: left; | text-align: left; | ||
Line 101: | Line 108: | ||
border: solid 1px #e7eceb; | border: solid 1px #e7eceb; | ||
margin: 15px; | margin: 15px; | ||
− | |||
} | } | ||
− | td | + | td{ |
− | padding: 10px; | + | padding: 15px; |
+ | padding-top: 10px; | ||
+ | padding-bottom: 10px; | ||
+ | } | ||
+ | |||
+ | th{ | ||
+ | padding: 15px; | ||
+ | padding-top: 10px; | ||
+ | padding-bottom: 10px; | ||
} | } | ||
Line 117: | Line 131: | ||
thead{ | thead{ | ||
− | background: # | + | background: #142968; |
color: #fefefe; | color: #fefefe; | ||
− | font-size: | + | font-size: 3vmin; |
} | } | ||
tbody{ | tbody{ | ||
− | font-size: | + | font-size: 2.5vmin; |
} | } | ||
Line 139: | Line 153: | ||
} | } | ||
+ | .expression{ | ||
+ | width: 50%; | ||
+ | margin-left: 25%; | ||
+ | margin-top: 50px; | ||
+ | margin-bottom: 10px; | ||
+ | } | ||
+ | .expression1{ | ||
+ | width: 15%; | ||
+ | display: inline-block; | ||
+ | margin-top: 50px; | ||
+ | margin-bottom: 10px; | ||
+ | } | ||
+ | .sec1{ | ||
+ | padding: 0; | ||
+ | padding-bottom: 50px; | ||
+ | padding-top: 50px; | ||
+ | margin: 0; | ||
+ | border: 0; | ||
+ | overflow: hidden; | ||
+ | } | ||
+ | .sec2{ | ||
+ | padding: 0; | ||
+ | margin: 0; | ||
+ | border: 0; | ||
+ | overflow: hidden; | ||
+ | } | ||
+ | |||
+ | .cloning{ | ||
+ | margin-left: 27.5%; | ||
+ | width: 45%; | ||
+ | } | ||
+ | |||
+ | .clone{ | ||
+ | width: 100%; | ||
+ | } | ||
+ | |||
+ | .sds{ | ||
+ | width: 50%; | ||
+ | margin-left: 25%; | ||
+ | } | ||
+ | |||
+ | #sds_3{ | ||
+ | width: 26.8%; | ||
+ | margin-left: 21.6%; | ||
+ | } | ||
+ | |||
+ | .protein{ | ||
+ | position: absolute; | ||
+ | width: 12%; | ||
+ | left: 23.5%; | ||
+ | top: 15.8vw; | ||
+ | transition-duration: 0.4s; | ||
+ | } | ||
+ | |||
+ | .mic{ | ||
+ | position: absolute; | ||
+ | width: 12%; | ||
+ | left: 51.5%; | ||
+ | top: 11.4vw; | ||
+ | transition-duration: 0.4s; | ||
+ | } | ||
+ | |||
+ | .sensor{ | ||
+ | position: absolute; | ||
+ | width: 12%; | ||
+ | left: 82.5%; | ||
+ | top: 16vw; | ||
+ | transition-duration: 0.4s; | ||
+ | } | ||
+ | |||
+ | .protein:hover{ | ||
+ | transform: scale(1.2); | ||
+ | } | ||
+ | |||
+ | .growth:hover{ | ||
+ | transform: scale(1.2); | ||
+ | } | ||
+ | |||
+ | .mic:hover{ | ||
+ | transform: scale(1.2); | ||
+ | } | ||
+ | |||
+ | .sensor:hover{ | ||
+ | transform: scale(1.2); | ||
+ | } | ||
+ | .sds_page{ | ||
+ | width: 60%; | ||
+ | margin-left: 20%; | ||
+ | } | ||
+ | .sds_entb{ | ||
+ | width: 30%; | ||
+ | margin-left: 35%; | ||
+ | margin-bottom: 1vw; | ||
+ | text-align: left; | ||
+ | } | ||
</style> | </style> | ||
Line 179: | Line 288: | ||
<div class="wrapper"> | <div class="wrapper"> | ||
<div class="banner"> | <div class="banner"> | ||
− | <img class="cover" src="https://static.igem.org/mediawiki/2018/ | + | <img class="cover" src="https://static.igem.org/mediawiki/2018/c/c5/T--NCTU_Formosa--wetlab6.png"> |
+ | <a href="https://2018.igem.org/Team:NCTU_Formosa/Wet_Lab/Expression"><img src="https://static.igem.org/mediawiki/2018/6/6e/T--NCTU_Formosa--protein_expression.png" class="protein"></a> | ||
+ | <a href="https://2018.igem.org/Team:NCTU_Formosa/Wet_Lab/Functional_Analysis"><img src="https://static.igem.org/mediawiki/2018/7/70/T--NCTU_Formosa--MIC.png" class="mic"></a> | ||
+ | <a href="https://2018.igem.org/Team:NCTU_Formosa/Wet_Lab/Curcumin_Biosensor"><img src="https://static.igem.org/mediawiki/2018/2/20/T--NCTU_Formosa--biosensor.png" class="sensor"></a> | ||
</div> | </div> | ||
− | <div class="sec1"> | + | <div class="sec1" style="background-color:#fff;"> |
− | <div class=" | + | <img src="https://static.igem.org/mediawiki/2018/a/ad/T--NCTU_Formosa--Expression_design_title.png" class="title_title"> |
+ | <div class="title_1"><p>Cloning</p></div> | ||
+ | <div class="text"> | ||
+ | <p> To ensure our target genes were successfully cloned into the pSB1C3 backbone, we ran the electrophoresis of Taq PCR products to check the sizes of the insert genes.</p> | ||
+ | </div> | ||
+ | <div class="text"> | ||
+ | <p>All of the sequences contained T7 promoter, RBS, bacteriocin, intein and CBD, were shown in Figure 1.</p> | ||
+ | </div> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/a/aa/T--NCTU_Formosa--biobrick.png" class="expression"> | ||
+ | <div class="explanation"> | ||
+ | <svg class="icon" aria-hidden="true" data-prefix="fas" data-icon="arrow-circle-up" class="svg-inline--fa fa-arrow-circle-up fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M8 256C8 119 119 8 256 8s248 111 248 248-111 248-248 248S8 393 8 256zm143.6 28.9l72.4-75.5V392c0 13.3 10.7 24 24 24h16c13.3 0 24-10.7 24-24V209.4l72.4 75.5c9.3 9.7 24.8 9.9 34.3.4l10.9-11c9.4-9.4 9.4-24.6 0-33.9L273 107.7c-9.4-9.4-24.6-9.4-33.9 0L106.3 240.4c-9.4 9.4-9.4 24.6 0 33.9l10.9 11c9.6 9.5 25.1 9.3 34.4-.4z"></path></svg> | ||
+ | Figure 1: Our BioBrick design | ||
+ | </div> | ||
+ | <div class="text"> | ||
+ | <p> After amplification with PCR, all the PCR products' lengths are around 1200 b.p. The exact lengths are listed in Table 1.</p> | ||
+ | </div> | ||
<div class="table"> | <div class="table"> | ||
<table> | <table> | ||
Line 188: | Line 315: | ||
<p class="explanation"> | <p class="explanation"> | ||
<svg class="icon" aria-hidden="true" data-prefix="fas" data-icon="arrow-circle-down" class="svg-inline--fa fa-arrow-circle-down fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M504 256c0 137-111 248-248 248S8 393 8 256 119 8 256 8s248 111 248 248zm-143.6-28.9L288 302.6V120c0-13.3-10.7-24-24-24h-16c-13.3 0-24 10.7-24 24v182.6l-72.4-75.5c-9.3-9.7-24.8-9.9-34.3-.4l-10.9 11c-9.4 9.4-9.4 24.6 0 33.9L239 404.3c9.4 9.4 24.6 9.4 33.9 0l132.7-132.7c9.4-9.4 9.4-24.6 0-33.9l-10.9-11c-9.5-9.5-25-9.3-34.3.4z"></path></svg> | <svg class="icon" aria-hidden="true" data-prefix="fas" data-icon="arrow-circle-down" class="svg-inline--fa fa-arrow-circle-down fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M504 256c0 137-111 248-248 248S8 393 8 256 119 8 256 8s248 111 248 248zm-143.6-28.9L288 302.6V120c0-13.3-10.7-24-24-24h-16c-13.3 0-24 10.7-24 24v182.6l-72.4-75.5c-9.3-9.7-24.8-9.9-34.3-.4l-10.9 11c-9.4 9.4-9.4 24.6 0 33.9L239 404.3c9.4 9.4 24.6 9.4 33.9 0l132.7-132.7c9.4-9.4 9.4-24.6 0-33.9l-10.9-11c-9.5-9.5-25-9.3-34.3.4z"></path></svg> | ||
− | Table 1: The | + | Table 1: The DNA length of each BioBrick |
</p> | </p> | ||
</caption> | </caption> | ||
Line 194: | Line 321: | ||
<tr> | <tr> | ||
<th><p>Bacteriocin</p></th> | <th><p>Bacteriocin</p></th> | ||
− | <th><p> | + | <th style="text-align: center;"><p>Length</p></th> |
+ | <th style="text-align: center;"><p>Length of PCR product</p></th> | ||
</tr> | </tr> | ||
</thead> | </thead> | ||
<tbody> | <tbody> | ||
<tr> | <tr> | ||
− | <td> | + | <td><p>Leucocyclicin Q</p></td> |
− | <td> | + | <td style="text-align: center;"><p>186 b.p.</p></td> |
+ | <td style="text-align: center;"><p>1230 b.p.</p></td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td>Enterocin | + | <td><p>Enterocin B</p></td> |
− | <td> | + | <td style="text-align: center;"><p>210 b.p.</p></td> |
+ | <td style="text-align: center;"><p>1254 b.p.</p></td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td>Enterocin | + | <td><p>Enterocin 96</p></td> |
− | <td> | + | <td style="text-align: center;"><p>219 b.p.</p></td> |
+ | <td style="text-align: center;"><p>1263 b.p.</p></td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td> | + | <td><p>Lacticin Z</p></td> |
− | <td> | + | <td style="text-align: center;"><p>153 b.p.</p></td> |
+ | <td style="text-align: center;"><p>1197 b.p.</p></td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td>Bovicin HJ50</td> | + | <td><p>Bovicin HJ50</p></td> |
− | <td> | + | <td style="text-align: center;"><p>171 b.p.</p></td> |
+ | <td style="text-align: center;"><p>1215 b.p.</p></td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td>Durancin</td> | + | <td><p>Durancin TW-49M</p></td> |
− | <td> | + | <td style="text-align: center;"><p>213 b.p.</p></td> |
+ | <td style="text-align: center;"><p>1257 b.p.</p></td> | ||
</tr> | </tr> | ||
+ | </tbody> | ||
+ | </table> | ||
+ | </div> | ||
+ | <div class="text"> | ||
+ | <p> The figure 2 is electrophoresis results of the PCR products with marker on the left side and target gene on the right side. The lengths are labeled beside each band.</p> | ||
+ | </div> | ||
+ | <div class="cloning"> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/2/2b/T--NCTU_Formosa--exp_clone.png" class="clone"> | ||
+ | </div> | ||
+ | <div class="explanation" style="width: 80%; margin-left: 10%; text-align: justify;"><p> | ||
+ | <svg class="icon" aria-hidden="true" data-prefix="fas" data-icon="arrow-circle-up" class="svg-inline--fa fa-arrow-circle-up fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M8 256C8 119 119 8 256 8s248 111 248 248-111 248-248 248S8 393 8 256zm143.6 28.9l72.4-75.5V392c0 13.3 10.7 24 24 24h16c13.3 0 24-10.7 24-24V209.4l72.4 75.5c9.3 9.7 24.8 9.9 34.3.4l10.9-11c9.4-9.4 9.4-24.6 0-33.9L273 107.7c-9.4-9.4-24.6-9.4-33.9 0L106.3 240.4c-9.4 9.4-9.4 24.6 0 33.9l10.9 11c9.6 9.5 25.1 9.3 34.4-.4z"></path></svg> | ||
+ | Figure 2: Agarose gel electrophoretic patterns of Taq PCR products of six bacteriocin genes containing T7 promoter, RBS, gene segments of intein and CBD: (A) Leucocyclicin Q (BBa_K2599014, 1230 b.p.) (B) Enterocin B (BBa_K2599011, 1254 b.p.) (C) Bovicin HJ50 (BBa_K2599009, 1215 b.p.) (D) Lacticin Z (BBa_K2599013, 1197 b.p.) (E) Enterocin 96 (BBa_K2599012, 1263 b.p.) (F) Durancin TW-49M (BBa_K2599015, 1257 b.p.) | ||
+ | </p></div> | ||
+ | </div> | ||
+ | <div class="sec2" style="background-color:#ffffff;"> | ||
+ | <div class="title_1"><p>Protein Expression</p></div> | ||
+ | <div class="text"> | ||
+ | <p> After the expression from <i>E. coli</i> BL21 Rosetta-gami, we had to check whether the proteins were successfully expressed. We broke <i>E. coli</i> with sonication and ran SDS-PAGE to check the correct sizes of the target proteins. The mass of each protein is presented in Table 2.</p> | ||
+ | </div> | ||
+ | <div class="table"> | ||
+ | <table> | ||
+ | <caption> | ||
+ | <p class="explanation"> | ||
+ | <svg class="icon" aria-hidden="true" data-prefix="fas" data-icon="arrow-circle-down" class="svg-inline--fa fa-arrow-circle-down fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M504 256c0 137-111 248-248 248S8 393 8 256 119 8 256 8s248 111 248 248zm-143.6-28.9L288 302.6V120c0-13.3-10.7-24-24-24h-16c-13.3 0-24 10.7-24 24v182.6l-72.4-75.5c-9.3-9.7-24.8-9.9-34.3-.4l-10.9 11c-9.4 9.4-9.4 24.6 0 33.9L239 404.3c9.4 9.4 24.6 9.4 33.9 0l132.7-132.7c9.4-9.4 9.4-24.6 0-33.9l-10.9-11c-9.5-9.5-25-9.3-34.3.4z"></path></svg> | ||
+ | Table 2. Mass of peptides with intein(kDa). | ||
+ | </p> | ||
+ | </caption> | ||
+ | <thead> | ||
<tr> | <tr> | ||
− | < | + | <th><p>Bacteriocin</p></th> |
− | < | + | <th><p style="white-space: nowrap;">Mass (kDa)</p></th> |
+ | <th><p style="white-space: nowrap;">Mass of peptides with intein</p></th> | ||
</tr> | </tr> | ||
+ | </thead> | ||
+ | <tbody> | ||
<tr> | <tr> | ||
− | <td>Lacticin Z</td> | + | <td><p style="white-space: nowrap;">Leucocyclicin Q</p></td> |
− | <td>5.9</td> | + | <td style="text-align: center;"><p>6.4</p></td> |
+ | <td style="text-align: center;"><p>34.4</p></td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td><p>Enterocin B</p></td> | ||
+ | <td style="text-align: center;"><p>7.5</p></td> | ||
+ | <td style="text-align: center;"><p>35.5</p></td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td><p>Bovicin HJ50</p></td> | ||
+ | <td style="text-align: center;"><p>6.25</p></td> | ||
+ | <td style="text-align: center;"><p>34.25</p></td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td><p>Enterocin 96</p></td> | ||
+ | <td style="text-align: center;"><p>7.9</p></td> | ||
+ | <td style="text-align: center;"><p>35.9</p></td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td><p>Lacticin Z</p></td> | ||
+ | <td style="text-align: center;"><p>5.9</p></td> | ||
+ | <td style="text-align: center;"><p>33.9</p></td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td><p style="white-space: nowrap;">Durancin TW-49M</p></td> | ||
+ | <td style="text-align: center;"><p>7.3</p></td> | ||
+ | <td style="text-align: center;"><p>35.3</p></td> | ||
</tr> | </tr> | ||
</tbody> | </tbody> | ||
Line 235: | Line 426: | ||
<div class="text"> | <div class="text"> | ||
<p> | <p> | ||
− | + | The gel of SDS-PAGE results were shown below. The mass of intein-CBD tag is 28 kDa. Therefore, all the results showed the initial mass of each bacteriocin plus the mass of intein-CBD tag. From SDS-PAGE results, we could confirm the production of target peptides. | |
</p> | </p> | ||
</div> | </div> | ||
− | <img src="https://static.igem.org/mediawiki/2018/ | + | <img src="https://static.igem.org/mediawiki/2018/f/f2/T--NCTU_Formosa--exp_SDS.png" class="sds_page"> |
− | <img src="https://static.igem.org/mediawiki/2018/ | + | <div class="explanation" style="width: 80%; margin-left: 10%; text-align: justify;"><p> |
+ | <svg class="icon" aria-hidden="true" data-prefix="fas" data-icon="arrow-circle-up" class="svg-inline--fa fa-arrow-circle-up fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M8 256C8 119 119 8 256 8s248 111 248 248-111 248-248 248S8 393 8 256zm143.6 28.9l72.4-75.5V392c0 13.3 10.7 24 24 24h16c13.3 0 24-10.7 24-24V209.4l72.4 75.5c9.3 9.7 24.8 9.9 34.3.4l10.9-11c9.4-9.4 9.4-24.6 0-33.9L273 107.7c-9.4-9.4-24.6-9.4-33.9 0L106.3 240.4c-9.4 9.4-9.4 24.6 0 33.9l10.9 11c9.6 9.5 25.1 9.3 34.4-.4z"></path></svg> | ||
+ | Figure 3: SDS-PAGE analysis of bacteriocin samples. M: Protein Ladder 5–245 kDa, C: Negative control (only intein+CBD, 28 kDa),<br> | ||
+ | E<sub>A</sub>: Leucocyclicin Q + intein + CBD (BBa_K2599014, 34.4 kDa) E<sub>B</sub>: Enterocin B + intein + CBD (BBa_K2599011, 35.5 kDa) E<sub>C</sub>: Bovicin HJ50 + intein + CBD (BBa_K2599009, 34.25 kDa) E<sub>D</sub>: Enterocin 96 + intein + CBD (BBa_K2599012, 35.9 kDa) E<sub>E</sub>: Lacticin Z + intein + CBD (BBa_K2599013, 33.9 kDa) E<sub>F</sub>: Durancin TW-49M + intein + CBD(BBa_K2599015, 35.3 kDa) | ||
+ | </p> | ||
+ | </div> | ||
+ | <div class="sec2" style="background-color:#ffffff;"> | ||
+ | <div class="title_1"><p>Protein Purification</p></div> | ||
+ | <div class="text"> | ||
+ | <p> Finally, we added 1,4-dithiothreitol(DTT) to purify bacteriocins from intein-CBD tag(28 kDa). The result is shown as below. We used Enterocin B as representative. The result showed that we could successfully purify bacteriocin.</p> | ||
+ | </div> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/6/6f/T--NCTU_Formosa--entb11.png" class="sds_entb"> | ||
<div class="explanation"> | <div class="explanation"> | ||
<svg class="icon" aria-hidden="true" data-prefix="fas" data-icon="arrow-circle-up" class="svg-inline--fa fa-arrow-circle-up fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M8 256C8 119 119 8 256 8s248 111 248 248-111 248-248 248S8 393 8 256zm143.6 28.9l72.4-75.5V392c0 13.3 10.7 24 24 24h16c13.3 0 24-10.7 24-24V209.4l72.4 75.5c9.3 9.7 24.8 9.9 34.3.4l10.9-11c9.4-9.4 9.4-24.6 0-33.9L273 107.7c-9.4-9.4-24.6-9.4-33.9 0L106.3 240.4c-9.4 9.4-9.4 24.6 0 33.9l10.9 11c9.6 9.5 25.1 9.3 34.4-.4z"></path></svg> | <svg class="icon" aria-hidden="true" data-prefix="fas" data-icon="arrow-circle-up" class="svg-inline--fa fa-arrow-circle-up fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><path fill="currentColor" d="M8 256C8 119 119 8 256 8s248 111 248 248-111 248-248 248S8 393 8 256zm143.6 28.9l72.4-75.5V392c0 13.3 10.7 24 24 24h16c13.3 0 24-10.7 24-24V209.4l72.4 75.5c9.3 9.7 24.8 9.9 34.3.4l10.9-11c9.4-9.4 9.4-24.6 0-33.9L273 107.7c-9.4-9.4-24.6-9.4-33.9 0L106.3 240.4c-9.4 9.4-9.4 24.6 0 33.9l10.9 11c9.6 9.5 25.1 9.3 34.4-.4z"></path></svg> | ||
− | Figure : | + | Figure 4: The purification of Enterocin B.<br> |
+ | <p>M: Protein Ladder 5–245 kDa;<br> | ||
+ | C: Negative control. Enterocin B without purification(35.5 kDa);<br> | ||
+ | E: Experimental group. The purified Enterocin B(7.5 kDa).</p> | ||
</div> | </div> | ||
</div> | </div> | ||
Line 248: | Line 453: | ||
<!-----------------------------------------------------------------------------> | <!-----------------------------------------------------------------------------> | ||
− | |||
− | |||
</div> | </div> | ||
+ | </div> | ||
</body> | </body> | ||
</html> | </html> | ||
+ | {{NCTU_Formosa/Top_button}} | ||
{{NCTU_Formosa/Footer}} | {{NCTU_Formosa/Footer}} |
Latest revision as of 15:20, 7 December 2018
![](https://static.igem.org/mediawiki/2018/f/ff/T--NCTU_Formosa--Navigation.png)
![](https://static.igem.org/mediawiki/2018/a/ad/T--NCTU_Formosa--Expression_design_title.png)
Cloning
All of the sequences contained T7 promoter, RBS, bacteriocin, intein and CBD, were shown in Figure 1.
![](https://static.igem.org/mediawiki/2018/a/aa/T--NCTU_Formosa--biobrick.png)
After amplification with PCR, all the PCR products' lengths are around 1200 b.p. The exact lengths are listed in Table 1.
Bacteriocin |
Length |
Length of PCR product |
---|---|---|
Leucocyclicin Q |
186 b.p. |
1230 b.p. |
Enterocin B |
210 b.p. |
1254 b.p. |
Enterocin 96 |
219 b.p. |
1263 b.p. |
Lacticin Z |
153 b.p. |
1197 b.p. |
Bovicin HJ50 |
171 b.p. |
1215 b.p. |
Durancin TW-49M |
213 b.p. |
1257 b.p. |
The figure 2 is electrophoresis results of the PCR products with marker on the left side and target gene on the right side. The lengths are labeled beside each band.
![](https://static.igem.org/mediawiki/2018/2/2b/T--NCTU_Formosa--exp_clone.png)
Figure 2: Agarose gel electrophoretic patterns of Taq PCR products of six bacteriocin genes containing T7 promoter, RBS, gene segments of intein and CBD: (A) Leucocyclicin Q (BBa_K2599014, 1230 b.p.) (B) Enterocin B (BBa_K2599011, 1254 b.p.) (C) Bovicin HJ50 (BBa_K2599009, 1215 b.p.) (D) Lacticin Z (BBa_K2599013, 1197 b.p.) (E) Enterocin 96 (BBa_K2599012, 1263 b.p.) (F) Durancin TW-49M (BBa_K2599015, 1257 b.p.)
Protein Expression
After the expression from E. coli BL21 Rosetta-gami, we had to check whether the proteins were successfully expressed. We broke E. coli with sonication and ran SDS-PAGE to check the correct sizes of the target proteins. The mass of each protein is presented in Table 2.
Bacteriocin |
Mass (kDa) |
Mass of peptides with intein |
---|---|---|
Leucocyclicin Q |
6.4 |
34.4 |
Enterocin B |
7.5 |
35.5 |
Bovicin HJ50 |
6.25 |
34.25 |
Enterocin 96 |
7.9 |
35.9 |
Lacticin Z |
5.9 |
33.9 |
Durancin TW-49M |
7.3 |
35.3 |
The gel of SDS-PAGE results were shown below. The mass of intein-CBD tag is 28 kDa. Therefore, all the results showed the initial mass of each bacteriocin plus the mass of intein-CBD tag. From SDS-PAGE results, we could confirm the production of target peptides.
![](https://static.igem.org/mediawiki/2018/f/f2/T--NCTU_Formosa--exp_SDS.png)
Figure 3: SDS-PAGE analysis of bacteriocin samples. M: Protein Ladder 5–245 kDa, C: Negative control (only intein+CBD, 28 kDa),
EA: Leucocyclicin Q + intein + CBD (BBa_K2599014, 34.4 kDa) EB: Enterocin B + intein + CBD (BBa_K2599011, 35.5 kDa) EC: Bovicin HJ50 + intein + CBD (BBa_K2599009, 34.25 kDa) ED: Enterocin 96 + intein + CBD (BBa_K2599012, 35.9 kDa) EE: Lacticin Z + intein + CBD (BBa_K2599013, 33.9 kDa) EF: Durancin TW-49M + intein + CBD(BBa_K2599015, 35.3 kDa)
Protein Purification
Finally, we added 1,4-dithiothreitol(DTT) to purify bacteriocins from intein-CBD tag(28 kDa). The result is shown as below. We used Enterocin B as representative. The result showed that we could successfully purify bacteriocin.
![](https://static.igem.org/mediawiki/2018/6/6f/T--NCTU_Formosa--entb11.png)
M: Protein Ladder 5–245 kDa;
C: Negative control. Enterocin B without purification(35.5 kDa);
E: Experimental group. The purified Enterocin B(7.5 kDa).
![](https://static.igem.org/mediawiki/2018/e/e8/T--NCTU_Formosa--top.png)